ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

ClinicalTrials.gov ID: NCT03614923

Public ClinicalTrials.gov record NCT03614923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Investigate Etokimab (ANB020) in Adult Subjects With Chronic Rhinosinusitis With Nasal Polyposis

Study identification

NCT ID
NCT03614923
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnaptysBio, Inc.
Industry
Enrollment
105 participants

Conditions and interventions

Interventions

  • Etokimab Biological
  • Mometasone Furoate Nasal Spray Drug
  • Placebo Biological

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2018
Primary completion
Sep 1, 2020
Completion
Oct 25, 2020
Last update posted
Jan 23, 2022

2018 – 2020

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Asthma & Allergy Institute Little Rock Arkansas 72209
Alliance Research Institute Canoga Park California 91304
DaVinci Research Roseville California 95661
Sacramento Ear Nose and Throat Surgical and Medical Group Inc. - SacENT Sacramento California 95815
Allergy & Asthma Medical Group and Research Center San Diego California 92123
Colorado Allergy Asthma Centers Denver Colorado 80230
Intermed Medical Research Center Miami Florida 33175
Advanced Research Institute, Inc. New Port Richey Florida 34653
Clinical Research Consultants of Atlanta Suwanee Georgia 30024
Treasure Valley Medical Research Boise Idaho 83706
Chicago ENT Chicago Illinois 60657
Advanced ENT and Allergy Louisville Kentucky 40213
Chesapeake Clinical Research Inc. Baltimore Maryland 21236
ENT and Allergy Associates ENTA LLP New York New York 10016
University of North Carolina Hospitals Chapel Hill North Carolina 27599
Charlotte Eye Ear Nose and Throat Associates Matthews North Carolina 28105
Ohio Sinus Institute Dublin Ohio 43016
Allergy Asthma Clinical Research Center Oklahoma City Oklahoma 73120
Allergy Asthma and Immunology Center P.C. Tulsa Oklahoma 74136
Central States Research, LLC Tulsa Oklahoma 74136
National Allergy and Asthma Research North Charleston South Carolina 29420
Fort Worth ENT Berkson Medical Fort Worth Texas 76109
Ear Nose and Throat Associates of Texas McKinney Texas 75070
Intermountain Ear Nose Throat Specialist Draper Utah 84020
Chrysalis Clinical Research St. George Utah 84790
Eastern Virginia Medical School EVMS Medical Group Norfolk Virginia 23507
Bellingham Asthma Allergy Immunology Clinic Bellingham Washington 98225
Allergy, Asthma Sinus Center, SC Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03614923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2022 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03614923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →